Company Search:
Advanced Search
Sponsored Links
Amgen Inc. Company Snapshot
Amgen Inc. operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Amgen Inc. with three other companies in this sector in the United States: Biogen Inc (2017 sales of $12.27 billion of which 100% was Novel Therapeutics), Gilead Sciences, Inc. ($26.11 billion of which 89% was Antiviral products), and Grifols SA ($4.92 billion of which 79% was Bioscience).

Sales Analysis. Amgen Inc. reported sales of $22.85 billion for the year ending December of 2017. This represents a decrease of 0.6% versus 2016, when the company's sales were $22.99 billion.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Amgen Inc.
  Stock Performance Chart for Amgen Inc.
  Stock Data: Recent Stock Performance:
  Current Price (1/11/2019): 200.56
(Figures in U.S. Dollars)
1 Week 2.6%   13 Weeks 4.4%  
4 Weeks 1.6%   52 Weeks 8.4%  
Amgen Inc. Key Data:
  Ticker: AMGN Country: United States
  Exchanges: NAS FRA HKG MXK Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2017 Sales 22,849,000,000
(Year Ending Jan 2018).
Employees: 20,800
  Currency: U.S. Dollars Market Cap: 127,800,691,577
  Fiscal Yr Ends: December Shares Outstanding: 637,219,244
  Share Type: Common Closely Held Shares: 1,323,431
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.